In-depth interviews on dietary supplement labeling statements
Ended Awarded Last action
- Contract number
- 75F40122F19015
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $148,313
Award facts
- Contract value 100% obligated
- $148,313.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541820 Public Relations Agencies
- PSC
- B599 Special Studies/Analysis- Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $0 | |
| Original award | $148,313 |
About this award
The Food and Drug Administration (FDA) awarded a $148,313 firm fixed-price call order to Westat, Inc. on June 22, 2022, for in-depth interviews on dietary supplement labeling statements. The work is being performed in Rockville, Maryland, with an ultimate completion date of October 31, 2024. This contract was issued as a call under a Blanket Purchase Agreement (BPA), enabling the FDA to leverage an existing vendor relationship for rapid acquisition of specialized research services without conducting a full and open competition process. No small business set-aside designation applies to this award.
Westat, a large established government contractor headquartered in Rockville, Maryland, brings extensive experience conducting qualitative research and data collection for federal agencies across health, education, and scientific domains. The company's qualitative research capabilities align with the FDA's regulatory mission to understand consumer perceptions and labeling comprehension related to dietary supplements. This engagement supports the FDA's responsibility for dietary supplement oversight and labeling compliance under the Dietary Supplement Health and Education Act (DSHEA), leveraging Westat's proven track record in conducting consumer interviews and focus groups on behalf of the agency for multiple survey and research initiatives.
Quick answers
Who was awarded contract 75F40122F19015?
75F40122F19015 was awarded to Westat, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 22, 2022.
How much is contract 75F40122F19015 worth?
The government has obligated $148,313 on 75F40122F19015.
Is contract 75F40122F19015 an order under another contract?
Yes. 75F40122F19015 is a BPA call under GS23F0155K-75F40120A00018, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).
Was contract 75F40122F19015 competed?
The extent of competition for 75F40122F19015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award